{"name":"ISA Pharmaceuticals","slug":"isa-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRjd6d2d4Vnl0dlB3Rk1lbXN5NWxqaFljLTlrdGVZX2UtRjBBMnBMdzJwdkV5RUJQalRoNWxFbE5Sek5FZHpuazFhaEliQk5EZzVJQm5UbVhZdEF1bTF6LUtLcWhDRHVuaVJhNVFLNlM5OWdIVV9zX2lfMDEtWG55em1ldGkxNmNQR1Z2Nlo5M0ZfSFk?oc=5","date":"2026-04-08","type":"trial","source":"openPR.com","summary":"Human Papillomavirus Associated Cancer Clinical Trial - openPR.com","headline":"Human Papillomavirus Associated Cancer Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQX0ZOSC13YWlSTjZNRmpVN0tYaENXYktQSHNPdTNaYmhwTWUwRi1VOFlYUmJKbi04eHFtbEdPUE1pNGZIODBjdG9jYVNCY1BHakpHblRoVElQVERWQTE0V0trdmFUYzI1UUxkTnBmaVZwUW10U21salk4aXczb25TbFBwYjFYcHRUYlNhdzJxRW5GTnZPSmUweVpn?oc=5","date":"2026-04-04","type":"pipeline","source":"guardian.ng","summary":"Experts Push for Strategic Overhaul of Pharmacy Education - guardian.ng","headline":"Experts Push for Strategic Overhaul of Pharmacy Education","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPVGxya29RMXktNU1rZkhGZ2RnUTRsaW80di1mZU5UaFVXRVFoSDNwQXFUcldSRG40cDZ1RHdvdl9JWWpNc0E3UFVJTWVqUHNRUGVxRnZOemZyeDNzZXNhNlN6NWtNV096M0NKYVRfU2lFenFUa1JiTVoxZXAyazZ6eWZOVnZnZUlJM0FLQUpFV0c5Nm1PU29haHcyZElCRlpZc3ppMzA1S0NlY2k1X3lVMWVCSHlINW9nNWdvdEUwT0hxd080c3B1QzZ4R0ZqbmJXY2ZTNjRPejhBTENUSDR1VkFqcmVyZmVQdVhpOUo4cjlQTHptN1FkRmRnY1hkd3ZsSElib1J0TzBTbVBGWW1QSTFGLWhWMG1OUGJSZXN3UUE?oc=5","date":"2025-09-30","type":"pipeline","source":"PR Newswire","summary":"HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight - PR Newswire","headline":"HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Inno","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNWWdnOUhfNGxXTUZRS3dwaF9jX2tzbmZTNVlwSXEzNTUxYkxYaXZWcUZzcjliUG9uSjRFLWw2XzFKM05MY2NYZEg2ZUVCcEl3MWp0UDVqV0xsY2NLaXRLNVFBa3g5VDYyd3hRLWhuMVdKSDBlOEd0VlJLcFQwek1BOTczaTVFWVhJZWxqc0w2aTZrbWRZTkE2SGxWNnh4NW42VXZzRGtEYzZkQlowZExBSTFfcllxcXVlcGc?oc=5","date":"2025-05-12","type":"pipeline","source":"Labiotech.eu","summary":"ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy - Labiotech.eu","headline":"ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNeU9rRTFTNjRWaVNMalhVNURJOUY2UmF2RHdlcXJsR01Pb0JfZGZWektIbnk0eHo5bGVwck9UYWI4TE1ZUzctV0lZQ1d3Y1lYUUdtM3dXMGJuTmQtSXlWTkMzUFZUa0dKV1ZHbTg4UTF3d2ZId25LSVY0VjdXcFhUeEtuVWZPRGJDbHVvQTEwZ3NoVklxWVZidWpaZzU3MjRTT1YwZnFiTEdETkNzM0hhZ2lHeGRjelh1c2phdzNpRGY0NVNGZ2QyZTUzMFhReEtxcDhqZDhuVnBPRWM?oc=5","date":"2025-04-17","type":"pipeline","source":"statnews.com","summary":"RFK Jr. is back to criticizing vaccines, and Trump’s new drug-cost plan - statnews.com","headline":"RFK Jr. is back to criticizing vaccines, and Trump’s new drug-cost plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOTlItdElSeV9EVzhheGZxRzAyblVrWXRRUDB1NEV1T1JXYXgwM1YyUk1qUjR0QUl6MEhwNXB5d1VuZWlSbFZvYVRZYUhPWTJGd19rS0s5UVE4TkNnR1hYekM0Z1RJM1dZVHltVnJxaHFkUU1MVl85UUY2V2tOdmdJbndYcUVCRnozT2JkQThQR1lvRmRHMmdwVF9FNWhtTHZmTmdGUjFOSlBvMEk1dXV5SzBwamhIdjFNenhROWUySmV1SlA5dGgwOE53V0lZd0J6SFdrVDB0Qk40YnVWWklQUnpIalNuLVFoRlZ2QkJ2elZHM1diUWxjWGVOaERMRjZWVklZc01uVFhLMm5jWjdZdk5pX0pCbHc?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Cancer Vaccines Market on Track for Major Expansion in the - GlobeNewswire","headline":"Cancer Vaccines Market on Track for Major Expansion in the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQUUlVdDVVT0VqTDdUczdUZHpuRERHR0h3ZFZRUkhTN1E1UmJZMjltQUVtUU1LRFg5RHRFUlRQWTMxZ3hLRDgtNmdhS2RXQXJWY1o5M2JlXzAxQmJNWnIwVWhwZHU0NzkxM29sZlVoaUs3VEFGc29tOC16RnNMSTlsNUNqRDZGNU1fSlRzTVh3bWtISDRWWGROMzliTjd2c2dPOFRTdlFReWpXcnhDNzFmNDRtSWNsS3phbXFOU2k0aW1EMWVSc0JLNQ?oc=5","date":"2023-12-12","type":"trial","source":"Fierce Biotech","summary":"ISA sees cancer vaccine fail in phase 2, loses Regeneron’s interest but still plans path to market - Fierce Biotech","headline":"ISA sees cancer vaccine fail in phase 2, loses Regeneron’s interest but still plans path to market","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE51NGtEZjBDdnNjSFZzZDM3TG9YWkk5WlV4VFhGc1dnUjQ5UWhJY3k1dkZIajU2dlc1TnR1Z2d6amlVVEtaOWJpVlVCZFpPVTYwNGt1UnViTEhZbXM4Z0xvdWRQY0hHUlFnOW5uQnROc2xoTG1DZEJ2d2dZcw?oc=5","date":"2023-09-01","type":"trial","source":"Clinical Trials Arena","summary":"ISA Pharmaceuticals doses first patient in HEB-PEP drug trial - Clinical Trials Arena","headline":"ISA Pharmaceuticals doses first patient in HEB-PEP drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQelVfN1hmVlVyQzFfR1cyVG9jOE8ycnZFV1l1c2FIUjBwUXE3OEprcUcwTWFhMXVNclZfMmc5Mzg2aGZBRng3QmlPSVBGbjZ2elBwRlVoZUV1UHo0RzB6Z3h3NEtNM29xR05BSkZVZWxnbHFBU3hkUkFIRFJoT1RnTFdHUU0?oc=5","date":"2022-06-23","type":"pipeline","source":"Labiotech.eu","summary":"Dutch and US Biotechs Team Up Against HPV-related Cancer - Labiotech.eu","headline":"Dutch and US Biotechs Team Up Against HPV-related Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOUTlXQWJFRVdvVzhjOEhHOVhsZ1VQdXBFQ0I5dGRUN2t3d0g0R1pXMllfZkg3V2U3MGZGd1JndVRsSkZod3NqRmpVZUVoMUtLUk1VcktTUVBoOWwwUXBZbi00cHBRdUNvV2k1dkE5d1I1WjdHY2tBSVJrSTVUQVQ3M2ZwQ2pGbzUxUm9HNi15RlR3UGxaa0V2TEg1MXcxSng0MkVGaWJiRFltYnlJanBsanI0c2llSkE?oc=5","date":"2021-07-13","type":"pipeline","source":"Fierce Biotech","summary":"Regeneron again backs ISA Pharma's HPV program in $30M funding round - Fierce Biotech","headline":"Regeneron again backs ISA Pharma's HPV program in $30M funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOcm5FRGRxVzhjTGlYWUMySDJ6Nk5tcXBiblgwZEVTMlhDcEN0V3hsbW10MEpTNjVxX0s3TzB3R1pjVU1ISEpQZC11T3h6Xzh4dlViaVBGSXoyakQxM0NCM3hTc3pQU2FFTHZkSXVXRVpxcFFVYzAzNE4ydVhfdFRnUWM4dXpKNkl6bjFEYm1kMHlzcnVYekgxTlF5SWNGdjQ0dXVyUXRPZEhoTWhScmZWY0xGRVBOdm9TQ0JzNUZ0X2I5aFV6?oc=5","date":"2020-10-25","type":"pipeline","source":"The ASCO Post","summary":"Long-Term Benefit of Adjuvant Immunotherapy Sustained in Stage III or IV Melanoma - The ASCO Post","headline":"Long-Term Benefit of Adjuvant Immunotherapy Sustained in Stage III or IV Melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQSGtRc3RDYmh6eXloSng4czNJbjVKQldIdldrTGpKZ0pTOXBDUWZfMmllLXJmMkxFdWxUYmZTLXZNOXZiWjhxVTlaUTM1SmFoRGpqTGtibEtxaUZOTTlCWlZ5aU40QnN4dWoxS0FyUExhRVRjSDlKMWx4WjFyb0ZIVlJ6RzdTamJnUGt4cDllY1ZmYkk?oc=5","date":"2017-12-18","type":"deal","source":"BioSpace","summary":"Regeneron, ISA Pharma Ink Strategic Immuno-Oncology Collaboration - BioSpace","headline":"Regeneron, ISA Pharma Ink Strategic Immuno-Oncology Collaboration","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}